Florent Petitprez
Florent Petitprez
University of Edinburgh, MRC Centre for Reproductive Health
Verified email at ed.ac.uk - Homepage
Title
Cited by
Cited by
Year
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
E Becht, NA Giraldo, L Lacroix, B Buttard, N Elarouci, F Petitprez, J Selves, ...
Genome biology 17 (1), 1-20, 2016
5182016
B cells and tertiary lymphoid structures promote immunotherapy response
BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ...
Nature 577 (7791), 549-555, 2020
3572020
B cells are associated with survival and immunotherapy response in sarcoma
F Petitprez, A de Reyniès, EZ Keung, TWW Chen, CM Sun, J Calderaro, ...
Nature 577 (7791), 556-560, 2020
3052020
Tertiary lymphoid structures in the era of cancer immunotherapy
C Sautès-Fridman, F Petitprez, J Calderaro, WH Fridman
Nature Reviews Cancer 19 (6), 307-325, 2019
2052019
Tumor-infiltrating and peripheral blood T-cell immunophenotypes predict early relapse in localized clear cell renal cell carcinoma
NA Giraldo, E Becht, Y Vano, F Petitprez, L Lacroix, P Validire, ...
Clinical Cancer Research 23 (15), 4416-4428, 2017
1352017
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
G Sturm, F Finotello, F Petitprez, JD Zhang, J Baumbach, WH Fridman, ...
Bioinformatics 35 (14), i436-i445, 2019
1182019
Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy
S Chauvet, V Frémeaux-Bacchi, F Petitprez, A Karras, L Daniel, S Burtey, ...
Blood 129 (11), 1437-1447, 2017
882017
The clinical role of the TME in solid cancer
NA Giraldo, R Sanchez-Salas, JD Peske, Y Vano, E Becht, F Petitprez, ...
British journal of cancer 120 (1), 45-53, 2019
822019
Context-dependent roles of complement in cancer
LT Roumenina, MV Daugan, F Petitprez, C Sautès-Fridman, WH Fridman
Nature Reviews Cancer 19 (12), 698-715, 2019
582019
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma
J Calderaro, F Petitprez, E Becht, A Laurent, TZ Hirsch, B Rousseau, ...
Journal of hepatology 70 (1), 58-65, 2019
552019
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
MC Marinozzi, S Chauvet, M Le Quintrec, M Mignotet, F Petitprez, ...
Kidney international 92 (5), 1232-1241, 2017
512017
Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies
F Petitprez, YA Vano, E Becht, NA Giraldo, A De Reyniès, ...
Cancer Immunology, Immunotherapy 67 (6), 981-988, 2018
502018
Tumor cells hijack macrophage-produced complement C1q to promote tumor growth
LT Roumenina, MV Daugan, R Noé, F Petitprez, YA Vano, ...
Cancer immunology research 7 (7), 1091-1105, 2019
422019
PD-L1 expression and CD8+ T-cell infiltrate are associated with clinical progression in patients with node-positive prostate cancer
F Petitprez, N Fossati, Y Vano, M Freschi, E Becht, R Lucianò, J Calderaro, ...
European urology focus 5 (2), 192-196, 2019
412019
Quantitative analyses of the tumor microenvironment composition and orientation in the era of precision medicine
F Petitprez, CM Sun, L Lacroix, C Sautès-Fridman, A de Reyniès, ...
Frontiers in oncology 8, 390, 2018
362018
Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
AM Weinstein, NA Giraldo, F Petitprez, C Julie, L Lacroix, F Peschaud, ...
Cancer Immunology, Immunotherapy 68 (1), 109-120, 2019
292019
Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome
J Zuber, M Frimat, S Caillard, N Kamar, P Gatault, F Petitprez, L Couzi, ...
Journal of the American Society of Nephrology 30 (12), 2449-2463, 2019
272019
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial
AM Di Giacomo, A Covre, F Finotello, D Rieder, R Danielli, L Sigalotti, ...
Clinical Cancer Research 25 (24), 7351-7362, 2019
212019
The tumor microenvironment in the response to immune checkpoint blockade therapies
F Petitprez, M Meylan, A de Reyniès, C Sautès-Fridman, WH Fridman
Frontiers in immunology 11, 2020
182020
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
M Dajon, K Iribarren, F Petitprez, S Marmier, A Lupo, M Gillard, H Ouakrim, ...
Oncoimmunology 8 (1), e1505174, 2019
172019
The system can't perform the operation now. Try again later.
Articles 1–20